Cancer Risk of Insulin Key Focus at ADA

ADA 2012 — PHILADELPHIA — Clinicians are hoping to get some answers about whether insulin analogs raise the risk of cancer from analyses of two large registries that will be presented at this year's American Diabetes Association meeting.


< Back to Listings